Lewis Rumpler

Inherent Biosciences, Inc. is a commercial-stage life science company based in Salt Lake City, UT. Inherent Biosciences has developed an epigenetic platform that detects gene dysregulation across multiple genes and related pathways to pioneer a new category of diagnostics and therapeutics that leverage epigenetics, biology's inherent mechanism for gene regulation, to radically transform how we diagnose and treat complex diseases like infertility. The company is actively involved in clinical trials to further validate its diagnostic tools. The company was founded by Kristin Brogaard and Andrew C. Olson, who has been the CEO since incorporation.

Inherent Biosciences, Inc. is a commercial-stage life science company based in Salt Lake City, UT. Inherent Biosciences has developed an epigenetic platform that detects gene dysregulation across multiple genes and related pathways to pioneer a new category of diagnostics and therapeutics that leverage epigenetics, biology's inherent mechanism for gene regulation, to radically transform how we diagnose and treat complex diseases like infertility. The company is actively involved in clinical trials to further validate its diagnostic tools. The company was founded by Kristin Brogaard and Andrew C. Olson, who has been the CEO since incorporation.

Inherent Biosciences, Inc. is a commercial-stage life science company based in Salt Lake City, UT. Inherent Biosciences has developed an epigenetic platform that detects gene dysregulation across multiple genes and related pathways to pioneer a new category of diagnostics and therapeutics that leverage epigenetics, biology's inherent mechanism for gene regulation, to radically transform how we diagnose and treat complex diseases like infertility. The company is actively involved in clinical trials to further validate its diagnostic tools. The company was founded by Kristin Brogaard and Andrew C. Olson, who has been the CEO since incorporation.

Inherent Biosciences, Inc. is a commercial-stage life science company based in Salt Lake City, UT. Inherent Biosciences has developed an epigenetic platform that detects gene dysregulation across multiple genes and related pathways to pioneer a new category of diagnostics and therapeutics that leverage epigenetics, biology's inherent mechanism for gene regulation, to radically transform how we diagnose and treat complex diseases like infertility. The company is actively involved in clinical trials to further validate its diagnostic tools. The company was founded by Kristin Brogaard and Andrew C. Olson, who has been the CEO since incorporation.

Inherent Biosciences, Inc. is a commercial-stage life science company based in Salt Lake City, UT. Inherent Biosciences has developed an epigenetic platform that detects gene dysregulation across multiple genes and related pathways to pioneer a new category of diagnostics and therapeutics that leverage epigenetics, biology's inherent mechanism for gene regulation, to radically transform how we diagnose and treat complex diseases like infertility. The company is actively involved in clinical trials to further validate its diagnostic tools. The company was founded by Kristin Brogaard and Andrew C. Olson, who has been the CEO since incorporation.